Skip to main content

Table 1 Clinical characteristics and biochemical parameters among peritoneal dialysis(PD) patients without metabolic syndrome (MetS, group 1), PD patients with MetS (group 2), and diabetes mellitus (DM) patients (group 3)

From: Metabolic syndrome and abdominal fat are associated with inflammation, but not with clinical outcomes, in peritoneal dialysis patients

 

1

2

3

Non-MetS, n = 73

MetS, n = 65

DM, n = 45

Mean

±

SD

Mean

±

SD

Mean

±

SD

Women

39

40

19

CAD

6

8

17*

Hypertension

55

58*

40

RAS blocker

37

34

19

Beta blocker

35

49*

28

Statin

17

24

18

Age

51

±

14

53

±

12

58

±

11*

PD vintage (months)

46

±

45

49

±

36

22

±

19*

Body weight (kg)

57

±

9

61

±

12*

68

±

13*

Renal KT/V

0.22

±

0.33

0.17

±

0.32

0.18

±

0.23

Peritoneal KT/V

1.87

±

0.41

1.92

±

0.35

1.79

±

0.31

4-h D/P Cre

0.67

±

0.10

0.64

±

0.09*

0.68

±

0.11

D4/D0 Glu

0.37

±

0.07

0.40

±

0.06*

0.39

±

0.07

Glucose exposure (kg/year)

53

±

19

56

±

20

58

±

22

Dialysate glucose load (g/dL)

1.86

±

0.33

1.87

±

0.31

2.11

±

0.31

nPCR (gm/[kg/day])

1.02

±

0.19

0.93

±

0.16*

0.90

±

0.21*

Albumin (g/mdL)

3.9

±

0.3

4.1

±

0.3*

4.0

±

0.4

Hemoglobin (g/dL)

10.2

±

1.2

10.0

±

1.6

10.2

±

1.0

Creatinine (mg/dL)

11.5

±

2.9

11.2

±

2.7

10.9

±

2.6

Glucose (mg/dL)

92

±

11

106

±

24*

139

±

52*

Cholesterol (mg/dL)

197

±

44

202

±

48

186

±

41

Triglyceride (mg/dL)

116

±

54

273

±

208*

203

±

133*

HDL (mg/dL)

48

±

15

37

±

7*

36

±

12*

LDL (mg/dL)

100

±

39

87

±

42

85

±

37*

AI1

0.36

±

0.25

0.80

±

0.26*

0.67

±

0.35*

AI2

3.31

±

1.31

4.58

±

1.31*

4.42

±

1.58*

CRP (mg/dL)

0.97

±

2.31

1.27

±

2.57a

1.11

±

1.35a

Cardiothoracic ratio (%)

48

±

7

50

±

7

53

±

6

SFA (cm2/[kg/m2])

4.8

±

2.4

6.1

±

2.0*

7.3

±

2.8*

TFA (cm2/[kg/m2])

8.0

±

3.6

10.7

±

3.4*

12.1

±

3.8*

VFA (cm2/[kg/m2])

3.2

±

1.8

4.6

±

1.9*

4.9

±

2.0*

  1. *P < 0.05 for comparison to group 1 patients by the student t-test.
  2. aP < 0.05 for comparison to group 1 patients by the non-parametric t-test.
  3. SD standard deviation, AI1 log (TG/HDL); AI2 non-HDL cholesterol/HDL, BMI Body mass index, CAD coronary artery disease, CRP C-reactive protein, HDL high density lipoprotein, LDL low density lipoprotein, RAS renin-angiotensin system, SFA subcutaneous fat area, TFA total fat area, VFA visceral fat area.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840